Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis

Surgery

Volumn 130, Issue 2, 2001, Pages 175-181

  Keck, Tobias ^a   Balcom, James H ^a   Antoniu, Bozena A ^a   Lewandrowski, Kent ^a   Warshaw, Andrew L ^a   Castillo, Carlos Fernández Del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CERULETIDE; COMPLEMENT INHIBITOR; GABEXATE; GLYCODEOXYCHOLIC ACID; HEPARIN; MYELOPEROXIDASE; NAFAMSTAT MESILATE; PROTEINASE INHIBITOR;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HISTOLOGY; INFLAMMATION; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT;

EID: 0034902166     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.115827     Document Type: Article

References (25)

1. The early intraacinar cell events which occur during acute pancreatitis
2. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury
3. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats
4. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.): A prospective, randomized, double-blind multicenter study
5. Gabexate mesilate in human acute pancreatitis: German Pancreatitis Study Group
6. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangio-pancreatography
7. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis
8. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin
9. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats
10. A better model of acute pancreatitis for evaluating therapy
11. Trypsinogen activation peptides in experimental rat pancreatitis: Prognostic implications and histopathologic correlates
12. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung
13. Treatment of acute pancreatitis: Comparison of animal and human studies
14. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis
15. Pharmakokinetic observations following intravenous administration of radioactively labelled aprotinin in volunteers
16. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat
17. Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretogogue stimulation
18. Interstitial protease activation is the central event in progression to necrotizing pancreatitis
19. Expression of Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement dependent
20. 2) and hydroxl radical production by human polymorphonuclear leukocytes
21. Degradation of the basement membrane by matrix metalloproteinase-9 enhances neutrophil transmigration in vivo and in vitro and contributes to neutrophil-related lung injury in acute necrotizing pancreatitis
22. FUT-175 inhibits the production of IL-6 and IL-8 in human monocytes
23. Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporal circulation
24. Effect of a synthetic protease inhibitor (FUT-175) on coagulation abnormalities during experimental acute pancreatitis in dogs
25. Which complications of acute pancreatitis are most lethal? A prospective evaluation of 719 episodes